PR Newswire Clinical TrialsOriginal article
Seegene propose une approche globale de dépistage des infections de l'appareil génital dans le cadre de la Global Million Clinical Study (GMCS)
Data ReadoutpositiveSTAgora™Positive
AI Analysis
Summary
Seegene's STAgora study of 60,000 test results demonstrated that sexually transmitted infection pathogens were detected in 82% of HPV-positive cases, supporting the potential value of a comprehensive screening approach for genital tract infections.
Clinical Trial Data
Primary Endpoint
Met
Patients
60,000
Outcome Details
STAgora study of ~60,000 test results over 42 months showed sexually transmitted infection pathogens detected in 82% of HPV-positive cases
Importance:5/10
Sentiment:
0.60
STI screeningHPV detectionGlobal Million Clinical Studydiagnostic testingmultiplex detection
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on August 10, 2026 7:00 AM